May 7, 2018 Cover
Volume 96, Issue 19
CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it
Cover:A joystick controller wired to the word CAR in the words "Controlling CAR T-cell therapy."
Credit: Yang H. Ku/C&EN/Shutterstock
Quote of the Week
Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers
CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it
Top 50 U.S. chemical producers of 2017
Sales rise as the new firm with 2 old names leads the ranking
Wine sleuths seek answers to the mystery of ‘smoke taint’
As wildfires increase in frequency across the globe, researchers hunt the smoke compounds that can seep into vineyards’ grapes and taint wine
-
Evonik keeps the faith in long-term research
German chemical maker seeks to balance technical support and basic R&D that can open new markets
-
Chemistry education moves from classroom to escape room
Chemistry teachers turn to puzzle-based activity to keep high school students engaged
-
Career Ladder: Yun He
Opportunities in academia and industry call chemist from China to the U.S.—and back again
Science Concentrates
New battery could serve the grid
Manganese-hydrogen design boasts high capacity, long life, and the promise of low cost
